Valeant Pharma (VRX) Swings to Q3 Loss; Declares $1.00 Special Dividend; Authorizes $1.5B Stock Buyback
Tweet Send to a Friend
Valeant Pharmaceuticals (NYSE: VRX) reports Q3 loss of $1.27, versus $0.25 reported for the same period a year ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
